Florida Cancer Specialists & Research Institute, LLC (FCS) has introduced a new technology that provides multiple benefits for cancer patients receiving radiation therapy at the FCS Ocala Cancer Center, the first and only comprehensive cancer center in Marion County.
Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD, will join an expert panel of precision medicine leaders in Chicago this weekend to discuss the impact of genomic profiling.
Florida Cancer Specialists & Research Institute, LLC (FCS) physicians are presenting the outcomes of 23 clinical trials, the majority being Phase 1, at the 2023 American Society of Clinical Oncology (ASCO®) Annual Meeting on June 2 – 6 in Chicago, Illinois.
A collaborative effort of Florida Cancer Specialists & Research Institute, LLC (FCS) and CVS Health/Aetna to integrate cancer care advancements within a value-driven framework is delivering improved quality and cost savings for Medicare patients enrolled in the insurer’s Oncology Medical Home Program.
Florida Cancer Specialists & Research Institute, LLC (FCS) has named Wilfredo Blasini, MD as Medical Director of the Central Pathology Laboratory. Dr. Blasini will provide clinical leadership and oversight for the centralized laboratory which serves the practice’s nearly 100 locations statewide with a comprehensive testing menu, including advanced next-generation sequencing (NGS). Dr. Blasini joined FCS in 2012 as a hematopathologist and has served as co-director of the Pathology Laboratory since 2018.
Florida Cancer Specialists & Research Institute, LLC (FCS) is demanding reform in the pricing regulation of generic drugs, an issue that has deeply affected the oncology community for years but has worsened in recent months. Inadequacies in regulating average selling prices (ASP) for regimens crucial to patient care are directly affecting manufacturers’ ability to maintain operations and productivity for critical generic drugs.
Florida Cancer Specialists & Research Institute (FCS) medical oncologist Dr. Ana Van Der Wall knew as a young child she wanted a career that would allow her to be independent and live her best life. Her mom, Tulia Gonzalez, helped pave the way for her to do that, and they have been together every step of the way.
FCS Top News Updates
FCS Expands Footprint Into St. Lucie County, Breaks Ground For New Cancer Center in Tradition
Can We Be Healthy at Any Size?Struggling to find the balance between health and size? Learn strategies for maintaining a healthy lifestyle while working towards your size goals.
FCS Implements New Surface Guided Technology for Improved Radiation TherapyFlorida Cancer Specialists & Research Institute, LLC (FCS) has introduced a new technology that provides multiple benefits for cancer patients receiving radiation therapy at the FCS Ocala Cancer Center, the first and only comprehensive cancer center in Marion County.
The Impact of Genomic Profiling on Cancer Treatment: Insights from FCS President and Managing PhysicianFlorida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD, will join an expert panel of precision medicine leaders in Chicago this weekend to discuss the impact of genomic profiling.
FCS Presents Cutting-Edge Clinical Research at 2023 ASCO® Annual MeetingFlorida Cancer Specialists & Research Institute, LLC (FCS) physicians are presenting the outcomes of 23 clinical trials, the majority being Phase 1, at the 2023 American Society of Clinical Oncology (ASCO®) Annual Meeting on June 2 – 6 in Chicago, Illinois.
Advanced Molecular Genetic Testing and Clinical Trial Research Capabilities Improve Care Quality and Reduce Costs for Medicare Cancer PatientsA collaborative effort of Florida Cancer Specialists & Research Institute, LLC (FCS) and CVS Health/Aetna to integrate cancer care advancements within a value-driven framework is delivering improved quality and cost savings for Medicare patients enrolled in the insurer’s Oncology Medical Home Program.
Wilfredo Blasini, MD Named Medical Director of FCS Pathology LabFlorida Cancer Specialists & Research Institute, LLC (FCS) has named Wilfredo Blasini, MD as Medical Director of the Central Pathology Laboratory. Dr. Blasini will provide clinical leadership and oversight for the centralized laboratory which serves the practice’s nearly 100 locations statewide with a comprehensive testing menu, including advanced next-generation sequencing (NGS). Dr. Blasini joined FCS in 2012 as a hematopathologist and has served as co-director of the Pathology Laboratory since 2018.
Nationwide Drug Shortage Calls for Immediate Reform on Pricing Regulation for Generic DrugsFlorida Cancer Specialists & Research Institute, LLC (FCS) is demanding reform in the pricing regulation of generic drugs, an issue that has deeply affected the oncology community for years but has worsened in recent months. Inadequacies in regulating average selling prices (ASP) for regimens crucial to patient care are directly affecting manufacturers’ ability to maintain operations and productivity for critical generic drugs.
A Mother’s Nursing Career Inspires Her Daughters Path to OncologyFlorida Cancer Specialists & Research Institute (FCS) medical oncologist Dr. Ana Van Der Wall knew as a young child she wanted a career that would allow her to be independent and live her best life. Her mom, Tulia Gonzalez, helped pave the way for her to do that, and they have been together every step of the way.